文献速递肿瘤 PET/CT骨显像与常规 SPECT

多参数盆腔与全身MRI对生化失败后前列腺癌PET/CT解读的贡献

The Contribution of Multiparametric Pelvic and Whole-Body MRI to Interpretation of 18F-Fluoromethylcholine or 68Ga-HBED-CC PSMA-11 PET/CT in Patients with Biochemical Failure After Radical Prostatectomy.
PubMed 文献 · J Nucl Med · 2019-03-22

本研究评估多参数盆腔MRI(mpMR)和全身MRI(wbMR)联合18F-FCH或68Ga-PSMA PET/CT是否提高根治性前列腺切除术后生化失败患者局部复发及转移的检出。结果显示PET/mpMR较单独PET显著提高局部肿瘤复发检出率,但wbMR联合PET未改善区域或远处转移的检出。

要点

  • PET/mpMR较单独PET显著提高局部肿瘤复发检出率(26.3% vs 14.5%,P=0.039)。
  • 联合wbMR检测前列腺窝外病变的灵敏度为50%,特异度为97.1%。

核心结论

  • PET/mpMR解读可提高根治性前列腺切除术后生化失败患者前列腺床局部肿瘤复发的检出率。
  • 将wbMR加入18F-FCH或68Ga-PSMA PET未改善区域或远处转移的检出。

研究设计与样本

  • 本分析为前瞻性多中心试验的一部分,纳入86例根治性前列腺切除术后生化失败且常规影像阴性或不确定的患者。
  • 患者接受18F-FCH(n=76)和/或68Ga-PSMA(n=26)PET/CT、mpMR和wbMR检查。
  • PET由2名放射科医生与mpMR和wbMR共识解读,并与单独PET或MRI的前瞻性解读及复合参考标准比较。

主要发现

  • 18F-FCH PET/mpMR检出局部肿瘤复发20/76(26.3%),高于单独PET的11/76(14.5%),P=0.039。
  • 68Ga-PSMA PET/mpMR检出局部肿瘤复发11/26(42.3%),高于单独PET的6/26(23.1%),P=0.074。
  • PET/wbMR与PET检出区域淋巴结转移均为20/86(23.3%),P=1.0;wbMR检出12/86(14%),P=0.061。
  • PET/wbMR检出非区域转移多于PET(P=0.683)或wbMR(P=0.074),但差异未达显著性。
  • 检测前列腺窝外病变,PET/wbMR、PET和wbMR的灵敏度分别为50%、50%和8.3%,特异度分别为97.1%、97.1%和94.1%。

关键数值与推荐

  • 生化失败定义为PSA>0.2 ng/mL,且具有高风险特征(Gleason评分>7、PSA倍增时间<10个月或PSA>1.0 ng/mL)。

临床怎么用

  • 对于根治性前列腺切除术后生化失败且常规影像阴性或不确定的患者,可考虑PET联合mpMR解读以提高局部复发检出。
  • 联合wbMR对区域或远处转移检出的增益有限,需结合其他临床信息综合判断。

局限性

  • wbMR联合PET对区域或远处转移检出的改善未达统计学显著性,需更大样本验证。
  • 68Ga-PSMA亚组样本量较小(n=26),局部复发检出差异未达显著性(P=0.074)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Our purpose was to assess whether the addition of data from multiparametric pelvic MRI (mpMR) and whole-body MRI (wbMR) to the interpretation of 18F-fluoromethylcholine (18F-FCH) or 68Ga-HBED-CC PSMA-11 (68Ga-PSMA) PET/CT (=PET) improves the detection of local tumor recurrence or of nodal and distant metastases in patients after radical prostatectomy with biochemical failure. Methods: The current analysis was performed as part of a prospective, multicenter trial on 18F-FCH or 68Ga-PSMA PET, mpMR, and wbMR. Eligible men had an elevated level of prostate-specific antigen (PSA) (>0.2 ng/mL) and high-risk features (Gleason score > 7, PSA doubling time < 10 mo, or PSA > 1.0 ng/mL) with negative or equivocal conventional imaging results. PET was interpreted with mpMR and wbMR in consensus by 2 radiologists and compared with prospective interpretation of PET or MRI alone. Performance measures of each modality (PET, MRI, and PET/mpMR-wbMR) were compared for each radiotracer and each individual patient (for 18F-FCH, or 68Ga-PSMA for patients who had 68Ga-PSMA PET) and to a composite reference standard. Results: There were 86 patients with PET (18F-FCH [n = 76] and/or 68Ga-PSMA [n = 26]) who had mpMR and wbMR. Local tumor recurrence was detected in 20 of 76 (26.3%) on 18F-FCH PET/mpMR, versus 11 of 76 (14.5%) on 18F-FCH PET (P = 0.039), and in 11 of 26 (42.3%) on 68Ga-PSMA PET/mpMR, versus 6 of 26 (23.1%) on 68Ga-PSMA PET (P = 0.074). Per patient, PET/mpMR was more often positive for local tumor recurrence than PET (P = 0.039) or mpMR (P = 0.019). There were 20 of 86 patients (23.3%) with regional nodal metastases on both PET/wbMR and PET (P = 1.0) but only 12 of 86 (14%) on wbMR (P = 0.061). Similarly, there were more nonregional metastases detected on PET/wbMR than on PET (P = 0.683) or wbMR (P = 0.074), but these differences did not reach significance. Compared with the composite reference standard for the detection of disease beyond the prostatic fossa, PET/wbMR, PET, and wbMR had sensitivity of 50%, 50%, and 8.3%, respectively, and specificity of 97.1%, 97.1%, and 94.1%, respectively. Conclusion: Interpretation of PET/mpMR resulted in a higher detection rate for local tumor recurrence in the prostatic bed in men with biochemical failure after radical prostatectomy. However, the addition of wbMR to 18F-FCH or 68Ga-PSMA PET did not improve detection of regional or distant metastases.

来源:J Nucl Med,查看原文。版权归原作者所有。

引用

  1. Metser U, Chua S, Ho B, et al. The Contribution of Multiparametric Pelvic and Whole-Body MRI to Interpretation of 18F-Fluoromethylcholine or 68Ga-HBED-CC PSMA-11 PET/CT in Patients with Biochemical Failure After Radical Prostatectomy. J Nucl Med. 2019. PMID: 30902875. doi:10.2967/jnumed.118.225185

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。